This page covers clinically feasible blistering skin conditions thesis ideas for MD Dermatology candidates, including pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid, dermatitis herpetiformis, linear immunoglobulin A bullous dermatosis, epidermolysis bullosa acquisita, mucous membrane pemphigoid, drug-induced vesiculobullous reactions and infectious blistering disorders that can usually be completed within one thesis period using patients, clinical examination and investigations already available in a dermatology department. The emphasis is on blistering skin conditions thesis topics, vesiculobullous skin disease research topics, dermatology blistering disease protocol and dermatology blistering disease synopsis choices that can be converted into a focused protocol or synopsis without making the project dependent on non-routine resources.
Last reviewed and updated: September 2026 · 2026–27 admissions
Pemphigus Vulgaris
- Clinical and epidemiological profile of pemphigus vulgaris and correlation of Pemphigus Disease Area Index with Dermatology Life Quality Index: a cross-sectional analytical study.
- Pattern of oral mucosal involvement in pemphigus vulgaris and its correlation with overall disease severity: a cross-sectional analytical study.
- Comparison of clinical severity and quality-of-life impairment in mucocutaneous and predominantly cutaneous pemphigus vulgaris: a comparative cross-sectional study.
- Diagnostic accuracy of Tzanck smear in clinically suspected pemphigus vulgaris using routine histopathology and clinically indicated direct immunofluorescence as reference standards.
- Correlation of Tzanck smear findings with Pemphigus Disease Area Index in active pemphigus vulgaris: a cross-sectional analytical study.
- Dermoscopic features of pemphigus vulgaris and their correlation with clinical morphology and activity: a cross-sectional analytical study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of pemphigus vulgaris: a cross-sectional study.
- Distribution of cutaneous lesions in pemphigus vulgaris and its association with disease severity: a cross-sectional observational study.
- Association of duration before diagnosis with disease severity at presentation in pemphigus vulgaris: a cross-sectional analytical study.
- Frequency and clinical predictors of secondary bacterial infection in pemphigus vulgaris: a cross-sectional analytical study.
- Gram stain and bacterial culture findings in clinically infected pemphigus vulgaris lesions and their correlation with clinical severity: a cross-sectional observational study.
- Comparison of clinical profile and severity of pemphigus vulgaris in younger and older adults: a comparative cross-sectional study.
- Quality-of-life impairment in pemphigus vulgaris and its relationship with oral disease burden: a cross-sectional analytical study.
- Clinical factors associated with extensive mucosal involvement in pemphigus vulgaris: a case-control study.
- Pattern of systemic corticosteroid-related cutaneous and metabolic adverse effects in patients with pemphigus vulgaris: a retrospective observational study.
- Clinical characteristics and precipitating factors associated with exacerbation of pemphigus vulgaris requiring hospitalisation: a retrospective observational study.
- Predictors of reduction in Pemphigus Disease Area Index within twelve weeks of routinely prescribed therapy for pemphigus vulgaris: a prospective observational study.
- Early adverse events within twelve weeks of routinely prescribed systemic treatment for pemphigus vulgaris: a prospective observational study.
- Comparison of short-term clinical response to established systemic treatment regimens used in routine practice for pemphigus vulgaris: a prospective observational study.
- Retrospective analysis of clinical presentation, treatment patterns and early outcomes of pemphigus vulgaris at a tertiary dermatology centre.
Pemphigus Foliaceus
- Clinical and epidemiological profile of pemphigus foliaceus and its association with disease extent and Dermatology Life Quality Index: a cross-sectional analytical study.
- Distribution and morphology of lesions in pemphigus foliaceus and their relationship with clinical severity: a cross-sectional analytical study.
- Dermoscopic features of pemphigus foliaceus and their correlation with clinical morphology: a cross-sectional study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of pemphigus foliaceus: a cross-sectional analytical study.
- Diagnostic accuracy of Tzanck smear in pemphigus foliaceus using routine histopathology and clinically indicated direct immunofluorescence as reference standards.
- Correlation between Tzanck smear findings and extent of disease in pemphigus foliaceus: a cross-sectional analytical study.
- Comparison of clinical and dermoscopic features of pemphigus foliaceus and pemphigus vulgaris: a comparative cross-sectional study.
- Comparison of quality-of-life impairment in pemphigus foliaceus and pemphigus vulgaris: a comparative cross-sectional study.
- Scalp involvement in pemphigus foliaceus and its association with overall disease extent: a cross-sectional analytical study.
- Facial involvement in pemphigus foliaceus and its relationship with disease severity and quality of life: a cross-sectional study.
- Frequency and clinical predictors of secondary bacterial infection in pemphigus foliaceus: a cross-sectional analytical study.
- Gram stain and bacterial culture profile of clinically infected lesions in pemphigus foliaceus: a cross-sectional observational study.
- Association of diagnostic delay with extent of disease at presentation in pemphigus foliaceus: a cross-sectional analytical study.
- Clinical factors associated with extensive pemphigus foliaceus: a case-control study.
- Comparison of localised and generalised pemphigus foliaceus with respect to clinical and dermoscopic characteristics: a comparative cross-sectional study.
- Pattern of systemic corticosteroid-related adverse effects among patients treated for pemphigus foliaceus: a retrospective observational study.
- Predictors of early clinical improvement within twelve weeks of routinely prescribed therapy in pemphigus foliaceus: a prospective observational study.
- Early adverse events during the first twelve weeks of routine systemic therapy for pemphigus foliaceus: a prospective observational study.
- Retrospective comparison of established treatment regimens used for pemphigus foliaceus in routine dermatology practice.
- Clinical presentation and treatment patterns of pemphigus foliaceus at a tertiary dermatology centre: a retrospective observational study.
Bullous Pemphigoid
- Clinical and epidemiological profile of bullous pemphigoid and its impact on Dermatology Life Quality Index: a cross-sectional analytical study.
- Distribution and morphology of lesions in bullous pemphigoid and their association with disease severity: a cross-sectional analytical study.
- Frequency and pattern of mucosal involvement in bullous pemphigoid: a cross-sectional observational study.
- Comparison of bullous pemphigoid with and without mucosal involvement regarding clinical severity and quality of life: a comparative cross-sectional study.
- Diagnostic accuracy of Tzanck smear in suspected bullous pemphigoid using routine histopathology and clinically indicated direct immunofluorescence as reference standards.
- Peripheral eosinophilia in bullous pemphigoid and its association with extent and severity of blistering: a cross-sectional analytical study.
- Comparison of bullous pemphigoid patients with and without peripheral eosinophilia regarding clinical phenotype: a comparative cross-sectional study.
- Dermoscopic patterns of bullous pemphigoid and their correlation with clinical morphology: a cross-sectional study.
- Dermoscopic-histopathological correlation in clinically indicated bullous pemphigoid lesions: a cross-sectional analytical study.
- Pruritus severity in bullous pemphigoid and its relationship with disease extent and Dermatology Life Quality Index: a cross-sectional analytical study.
- Frequency and microbiological profile of secondary bacterial infection in bullous pemphigoid: a cross-sectional observational study.
- Clinical factors associated with secondary infection in bullous pemphigoid: a case-control study.
- Comparison of localised and generalised bullous pemphigoid with respect to clinical and laboratory characteristics: a comparative cross-sectional study.
- Relationship between delay in diagnosis and disease extent at presentation in bullous pemphigoid: a cross-sectional analytical study.
- Clinical factors associated with extensive blistering in bullous pemphigoid: a case-control study.
- Pattern of systemic corticosteroid-related adverse effects in bullous pemphigoid: a retrospective observational study.
- Predictors of early clinical improvement within twelve weeks of routinely prescribed therapy for bullous pemphigoid: a prospective observational study.
- Early treatment-related adverse events within twelve weeks in patients with bullous pemphigoid: a prospective observational study.
- Comparison of short-term response to established treatment regimens used in routine practice for bullous pemphigoid: a prospective observational study.
- Retrospective analysis of clinical profile and treatment patterns of bullous pemphigoid at a tertiary dermatology centre.
Dermatitis Herpetiformis
- Clinical and epidemiological profile of dermatitis herpetiformis in patients attending a tertiary dermatology centre: a cross-sectional observational study.
- Distribution and morphology of lesions in dermatitis herpetiformis and their relationship with pruritus severity: a cross-sectional analytical study.
- Dermoscopic features of dermatitis herpetiformis and their correlation with clinical morphology: a cross-sectional observational study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of dermatitis herpetiformis: a cross-sectional study.
- Comparison of clinical features of dermatitis herpetiformis and other common pruritic vesiculobullous dermatoses: a comparative cross-sectional study.
- Diagnostic accuracy of routine histopathology in clinically suspected dermatitis herpetiformis using clinically indicated direct immunofluorescence as the reference standard.
- Quality-of-life impairment in dermatitis herpetiformis and its correlation with extent of cutaneous involvement: a cross-sectional analytical study.
- Pruritus severity and its association with clinical extent of dermatitis herpetiformis: a cross-sectional analytical study.
- Excoriations and secondary eczematization in dermatitis herpetiformis and their association with disease severity: a cross-sectional study.
- Frequency and pattern of scalp involvement in dermatitis herpetiformis: a cross-sectional observational study.
- Clinical characteristics of patients with dermatitis herpetiformis with and without gastrointestinal symptoms documented during routine care: a comparative cross-sectional study.
- Association of routine haematological abnormalities with clinical severity in dermatitis herpetiformis: a cross-sectional analytical study.
- Clinical factors associated with extensive dermatitis herpetiformis: a case-control study.
- Comparison of flexural and extensor-predominant dermatitis herpetiformis with respect to clinical features and quality of life: a comparative cross-sectional study.
- Association of diagnostic delay with extent of dermatitis herpetiformis at presentation: a cross-sectional analytical study.
- Secondary bacterial infection in excoriated dermatitis herpetiformis lesions: a cross-sectional observational study.
- Predictors of early symptomatic improvement within twelve weeks of routinely prescribed therapy for dermatitis herpetiformis: a prospective observational study.
- Early adverse effects of routinely prescribed dapsone therapy in dermatitis herpetiformis: a prospective observational study based on clinically indicated monitoring.
- Retrospective analysis of clinical presentation and treatment practices in dermatitis herpetiformis at a tertiary centre.
- Comparison of clinical severity and quality-of-life impairment before and within twelve weeks of routine treatment for dermatitis herpetiformis: a prospective observational study.
Linear Immunoglobulin A Bullous Dermatosis
- Clinical and epidemiological profile of linear immunoglobulin A bullous dermatosis at a tertiary dermatology centre: a retrospective observational study.
- Clinical morphology and distribution of lesions in linear immunoglobulin A bullous dermatosis: a cross-sectional observational study.
- Frequency and clinical pattern of mucosal involvement in linear immunoglobulin A bullous dermatosis: a cross-sectional observational study.
- Comparison of linear immunoglobulin A bullous dermatosis with bullous pemphigoid regarding morphology, distribution and mucosal involvement: a comparative cross-sectional study.
- Dermoscopic features of linear immunoglobulin A bullous dermatosis and their correlation with clinical morphology: a cross-sectional study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of linear immunoglobulin A bullous dermatosis: a cross-sectional analytical study.
- Diagnostic utility of routine histopathology in suspected linear immunoglobulin A bullous dermatosis using clinically indicated direct immunofluorescence as the reference standard.
- Peripheral eosinophilia in linear immunoglobulin A bullous dermatosis and its association with clinical severity: a cross-sectional analytical study.
- Quality-of-life impairment in adult linear immunoglobulin A bullous dermatosis and its association with disease extent: a cross-sectional analytical study.
- Clinical characteristics of paediatric linear immunoglobulin A bullous dermatosis: a retrospective observational study.
- Comparison of paediatric and adult linear immunoglobulin A bullous dermatosis with respect to morphology and distribution: a comparative retrospective study.
- Clinical factors associated with mucosal involvement in linear immunoglobulin A bullous dermatosis: a case-control study.
- Frequency and profile of secondary bacterial infection in linear immunoglobulin A bullous dermatosis: a cross-sectional observational study.
- Association of diagnostic delay with extent of disease in linear immunoglobulin A bullous dermatosis: a cross-sectional analytical study.
- Drug exposure patterns preceding onset of linear immunoglobulin A bullous dermatosis: a retrospective observational study.
- Comparison of suspected drug-associated and idiopathic linear immunoglobulin A bullous dermatosis: a comparative retrospective study.
- Predictors of early clinical improvement within twelve weeks of routinely prescribed therapy in linear immunoglobulin A bullous dermatosis: a prospective observational study.
- Early adverse effects of routinely prescribed therapy for linear immunoglobulin A bullous dermatosis: a prospective observational study.
- Short-term clinical response to established treatment regimens used in routine care for linear immunoglobulin A bullous dermatosis: a prospective observational study.
- Retrospective analysis of clinicopathological patterns and treatment practices in linear immunoglobulin A bullous dermatosis.
Epidermolysis Bullosa Acquisita
- Clinical profile of epidermolysis bullosa acquisita in patients presenting to a tertiary dermatology centre: a retrospective observational study.
- Distribution and morphology of mechanobullous lesions in epidermolysis bullosa acquisita: a cross-sectional observational study.
- Frequency and pattern of mucosal involvement in epidermolysis bullosa acquisita: a retrospective observational study.
- Scarring and milia formation in epidermolysis bullosa acquisita and their association with disease duration: a cross-sectional analytical study.
- Comparison of mechanobullous and inflammatory clinical phenotypes of epidermolysis bullosa acquisita: a comparative observational study.
- Dermoscopic characteristics of active and healed lesions of epidermolysis bullosa acquisita: a cross-sectional study.
- Dermoscopic-histopathological correlation in clinically indicated lesions of epidermolysis bullosa acquisita: a cross-sectional analytical study.
- Clinical and histopathological features useful in differentiating epidermolysis bullosa acquisita from bullous pemphigoid: a comparative cross-sectional study.
- Diagnostic utility of routine histopathology in suspected epidermolysis bullosa acquisita using clinically indicated direct immunofluorescence as the reference standard.
- Quality-of-life impairment in epidermolysis bullosa acquisita and its association with scarring and functional limitation: a cross-sectional analytical study.
- Frequency of nail changes in epidermolysis bullosa acquisita and their relationship with disease duration: a cross-sectional study.
- Clinical characteristics of acral involvement in epidermolysis bullosa acquisita: a cross-sectional observational study.
- Factors associated with extensive scarring in epidermolysis bullosa acquisita: a case-control study.
- Clinical factors associated with mucosal disease in epidermolysis bullosa acquisita: a case-control study.
- Secondary bacterial infection in chronic erosions of epidermolysis bullosa acquisita: a retrospective observational study.
- Association of diagnostic delay with scarring burden at presentation in epidermolysis bullosa acquisita: a cross-sectional analytical study.
- Predictors of early clinical improvement within twelve weeks of routine therapy for epidermolysis bullosa acquisita: a prospective observational study.
- Early treatment-related adverse events in epidermolysis bullosa acquisita during the first twelve weeks of routine therapy: a prospective observational study.
- Comparison of short-term clinical response among established treatment approaches used in routine care for epidermolysis bullosa acquisita: an observational study.
- Retrospective analysis of clinicopathological spectrum and management patterns of epidermolysis bullosa acquisita at a tertiary centre.
Mucous Membrane Pemphigoid
- Clinical and epidemiological profile of mucous membrane pemphigoid presenting to dermatology services: a retrospective observational study.
- Pattern and distribution of mucosal involvement in mucous membrane pemphigoid: a cross-sectional observational study.
- Comparison of patients with single-site and multisite mucosal involvement in mucous membrane pemphigoid: a comparative cross-sectional study.
- Frequency and clinical characteristics of cutaneous involvement in mucous membrane pemphigoid: a cross-sectional observational study.
- Oral manifestations of mucous membrane pemphigoid and their association with overall mucosal disease burden: a cross-sectional analytical study.
- Dermatology Life Quality Index impairment in mucous membrane pemphigoid and its association with cutaneous and oral involvement: a cross-sectional analytical study.
- Clinical factors associated with multisite mucosal involvement in mucous membrane pemphigoid: a case-control study.
- Diagnostic utility of routine histopathology in clinically suspected mucous membrane pemphigoid using clinically indicated direct immunofluorescence as the reference standard.
- Dermoscopic findings in cutaneous lesions of mucous membrane pemphigoid: a cross-sectional observational study.
- Dermoscopic-histopathological correlation in clinically indicated cutaneous lesions of mucous membrane pemphigoid: a cross-sectional study.
- Comparison of cutaneous features of mucous membrane pemphigoid and bullous pemphigoid: a comparative cross-sectional study.
- Association of diagnostic delay with extent of mucosal involvement in mucous membrane pemphigoid: a cross-sectional analytical study.
- Frequency of secondary infection in erosive mucous membrane pemphigoid lesions: a retrospective observational study.
- Clinical factors associated with scarring in mucous membrane pemphigoid: a case-control study.
- Comparison of patients with and without cutaneous lesions in mucous membrane pemphigoid: a comparative cross-sectional study.
- Pattern of treatment-related adverse effects among patients receiving routine systemic treatment for mucous membrane pemphigoid: a retrospective observational study.
- Predictors of early mucocutaneous improvement within twelve weeks of routinely prescribed therapy in mucous membrane pemphigoid: a prospective observational study.
- Early adverse events within twelve weeks of routine systemic treatment for mucous membrane pemphigoid: a prospective observational study.
- Retrospective comparison of established treatment approaches used for mucous membrane pemphigoid in routine practice.
- Clinicopathological spectrum and management patterns of mucous membrane pemphigoid at a tertiary dermatology centre: a retrospective observational study.
Drug-Induced Vesiculobullous Disorders
- Clinical spectrum of drug-induced vesiculobullous eruptions presenting to a tertiary dermatology centre: a retrospective observational study.
- Clinical and epidemiological profile of Stevens-Johnson syndrome and toxic epidermal necrolysis in dermatology inpatients: a retrospective observational study.
- Pattern of culprit drug classes in Stevens-Johnson syndrome and toxic epidermal necrolysis based on routinely documented drug histories: a retrospective observational study.
- Comparison of clinical characteristics of Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative retrospective study.
- Extent of epidermal detachment and pattern of mucosal involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analytical study.
- Association of number of mucosal sites involved with severity of epidermal detachment in Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analytical study.
- Cutaneous and mucosal patterns in drug-induced bullous fixed drug eruption: a cross-sectional observational study.
- Comparison of generalised bullous fixed drug eruption and Stevens-Johnson syndrome with respect to clinical morphology, distribution and mucosal involvement: a comparative cross-sectional study.
- Dermoscopic characteristics of bullous fixed drug eruption and their correlation with clinical morphology: a cross-sectional observational study.
- Dermoscopic-histopathological correlation in clinically indicated bullous fixed drug eruption lesions: a cross-sectional study.
- Clinical factors associated with generalised bullous fixed drug eruption: a case-control study.
- Pattern of previous exposure to implicated drugs among patients with bullous fixed drug eruption: a cross-sectional analytical study.
- Comparison of single-drug and multidrug exposure histories in patients with severe vesiculobullous drug reactions: a comparative cross-sectional study.
- Secondary bacterial infection in extensive drug-induced epidermal detachment: a retrospective observational study.
- Clinical predictors of early re-epithelialization within twelve weeks in Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective observational study.
- Short-term cutaneous and mucosal sequelae within twelve weeks after Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective observational study.
- Pattern of acute dermatological complications in Stevens-Johnson syndrome and toxic epidermal necrolysis during hospitalisation: a retrospective observational study.
- Comparison of short-term clinical outcomes among patients with early and delayed withdrawal of the suspected culprit drug in severe cutaneous adverse reactions: a retrospective observational study.
- Diagnostic agreement between initial clinical diagnosis and routine histopathological diagnosis in drug-induced vesiculobullous disorders: a cross-sectional study.
- Retrospective analysis of causative drugs, clinical patterns and early outcomes of vesiculobullous drug reactions at a tertiary dermatology centre.
Infectious Vesiculobullous Disorders
- Clinical and bacteriological profile of bullous impetigo in patients attending a dermatology department: a cross-sectional observational study.
- Gram stain and bacterial culture findings in bullous impetigo and their correlation with clinical extent: a cross-sectional analytical study.
- Comparison of bullous and non-bullous impetigo with respect to age distribution, lesion characteristics and bacterial isolates: a comparative cross-sectional study.
- Clinical factors associated with extensive bullous impetigo: a case-control study.
- Short-term clinical response of bullous impetigo to routinely prescribed antimicrobial therapy: a prospective observational study.
- Clinical and epidemiological profile of herpes zoster presenting with prominent vesiculobullous lesions: a cross-sectional observational study.
- Distribution and severity of vesiculobullous lesions in herpes zoster and their association with acute pain severity: a cross-sectional analytical study.
- Comparison of vesiculobullous manifestations of herpes zoster in younger and older adults: a comparative cross-sectional study.
- Dermoscopic findings in herpes zoster and their correlation with stage of vesicular evolution: a cross-sectional observational study.
- Tzanck smear findings in clinically suspected herpes zoster and their diagnostic accuracy using clinical diagnosis and routine follow-up response as reference standards.
- Clinical and Tzanck smear profile of herpes simplex presenting with vesiculobullous lesions: a cross-sectional observational study.
- Diagnostic accuracy of Tzanck smear in differentiating herpes simplex and herpes zoster from non-herpetic vesiculobullous dermatoses using routine clinical diagnosis as the reference standard.
- Comparison of clinical characteristics of herpes simplex and herpes zoster with vesiculobullous presentations: a comparative cross-sectional study.
- Secondary bacterial infection in herpes zoster lesions and its association with clinical severity: a cross-sectional analytical study.
- Clinical factors associated with bullous transformation in herpes zoster: a case-control study.
- Early cutaneous healing within four weeks of routine antiviral treatment in vesiculobullous herpes zoster: a prospective observational study.
- Immediate and early cutaneous complications of herpes zoster within twelve weeks of presentation: a prospective observational study.
- Clinical spectrum of vesiculobullous viral eruptions among dermatology patients: a cross-sectional observational study.
- Comparison of clinical diagnosis and Tzanck smear findings across common viral vesiculobullous disorders: a comparative cross-sectional study.
- Retrospective analysis of infectious vesiculobullous dermatoses requiring dermatology admission: a retrospective observational study.
Autoimmune and Inflammatory Vesiculobullous Disorders: Comparative Studies
- Comparative clinical profile of pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid in patients attending a tertiary dermatology centre: a comparative cross-sectional study.
- Diagnostic accuracy of Tzanck smear across pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid using routine clinicopathological diagnosis as the reference standard.
- Comparison of dermoscopic patterns in pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid: a comparative cross-sectional study.
- Correlation of dermoscopic and histopathological features across common autoimmune blistering diseases in clinically indicated biopsies: a cross-sectional analytical study.
- Comparison of mucosal involvement across pemphigus vulgaris, bullous pemphigoid and linear immunoglobulin A bullous dermatosis: a comparative cross-sectional study.
- Comparison of Dermatology Life Quality Index impairment across common autoimmune blistering disorders: a comparative cross-sectional study.
- Association between extent of skin involvement and quality-of-life impairment across autoimmune blistering diseases: a cross-sectional analytical study.
- Comparison of frequency and pattern of secondary bacterial infection among pemphigus vulgaris and bullous pemphigoid patients: a comparative cross-sectional study.
- Microbiological profile of clinically infected erosions in common autoimmune blistering diseases: a cross-sectional observational study.
- Clinical factors associated with secondary bacterial infection in autoimmune blistering diseases: a case-control study.
- Comparison of diagnostic delay among pemphigus vulgaris, pemphigus foliaceus and bullous pemphigoid and its relationship with disease extent: a comparative cross-sectional study.
- Comparison of peripheral eosinophilia in bullous pemphigoid, pemphigus vulgaris and other common autoimmune blistering diseases: a comparative cross-sectional study.
- Pattern of systemic corticosteroid-related cutaneous adverse effects across autoimmune blistering diseases: a cross-sectional observational study.
- Comparison of short-term adverse effects of established systemic treatment regimens used for autoimmune blistering diseases: a prospective observational study.
- Predictors of early clinical improvement within twelve weeks across common autoimmune blistering disorders receiving routine therapy: a prospective observational study.
- Comparison of early clinical response in pemphigus vulgaris and bullous pemphigoid during the first twelve weeks of established treatment: a prospective observational study.
- Clinical and histopathological concordance in common autoimmune vesiculobullous disorders: a cross-sectional analytical study.
- Factors associated with extensive mucocutaneous involvement among patients with autoimmune blistering diseases: a case-control study.
- Clinical spectrum and relative frequency of autoimmune blistering disorders diagnosed in a tertiary dermatology department: a retrospective observational study.
- Comparative analysis of clinical presentation, routine investigations and management patterns across common autoimmune blistering diseases at a tertiary dermatology centre: a retrospective observational study.
Not the dermatology subspeciality you need? Blistering skin conditions is one section of our full dermatology collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.
Browse all Dermatology Thesis Topics →
📌 Updated for 2026–2027 MD Dermatology Blistering Skin Conditions admissions
The proposed designs were reviewed for feasibility in routine dermatology services, with particular attention to Tzanck smear, lesion selection, histopathology, direct immunofluorescence, mucosal disease, secondary infection and short-term treatment outcomes.
- Most topics can be completed with clinical examination, disease-specific severity assessment, Tzanck smear, routine histopathology, direct immunofluorescence when clinically indicated and microbiology for clinically infected erosions.
- Advanced immunobullous serology, molecular testing and repeated research-only biopsy are generally not required for a feasible residency project.
- Publication potential is strongest when biopsy site, reference standard, mucosal assessment and treatment outcome definitions are fixed before enrolment.
Generate a protocol from any topic above
Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:
- Introduction / Synopsis
- Research Question
- Aim of the Study
- Primary Objective
- Secondary Objectives
- Materials and Methods
- Inclusion Criteria
- Exclusion Criteria
- Sample Size Calculation
- Methodology
- Statistical Analysis
- Ethical Considerations
- Review of Literature
- References
- Gantt Chart / Study Timeline
- Patient Information Sheet
- Consent Form
- Data Collection Form
Already have your thesis title?
Generate the full blistering skin conditions protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.
Generate your protocol
Alongside blistering skin conditions protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.
Enquire on WhatsApp →
Blistering skin conditions research outside India
The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the blistering skin conditions research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Board and residency programmes — country by country
Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the blistering skin conditions research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.
United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a blistering skin conditions research protocol for their programme and submit it for institutional review board approval before any data are collected.
Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A blistering skin conditions IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.
Bahrain — NHRA. Trainees turning blistering skin conditions research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.
Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the blistering skin conditions research proposal is the document assessed at the start of it.
Kuwait — KIMS. A blistering skin conditions study protocol goes to the institutional committee for approval before the project begins.
Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the blistering skin conditions proposal follows the same structure throughout.
Postgraduate degrees — Malaysia, the Gulf and beyond
Malaysia — MMed, the National Medical Research Register and MREC. A blistering skin conditions dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.
PhD and Master's candidates elsewhere. University programmes generally require a full blistering skin conditions research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.
PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.
Enquire about a blistering skin conditions PhD or MMed proposal →
🔥 Trending research areas in Blistering Skin Conditions for 2026–27
- Clinicopathological and direct immunofluorescence concordance remains important because biopsy-site selection and specimen handling can materially alter diagnostic yield.
- Mucosal disease burden is increasingly relevant because oral, ocular and multisite involvement may predict morbidity that is not captured by skin extent alone.
- Secondary infection and microbiological profiling are high-yield areas in erosive immunobullous disease because infection can complicate severity assessment and early treatment outcomes.
- Real-world early response and treatment toxicity are useful research areas because systemic corticosteroids, dapsone and other routine therapies can produce measurable benefits and adverse effects within a residency-compatible follow-up period.
Protocol and synopsis guidance
What a blistering skin conditions protocol must contain
A vesiculobullous disease protocol should first define whether the study concerns autoimmune blistering disease, drug-induced vesiculobullous reactions, infectious blistering disease or a comparative differential diagnosis. These groups have different reference standards and should not be pooled without a clear rationale.
Diagnostic pathway: State the role of clinical morphology, Nikolsky sign, Tzanck smear, histopathology, direct immunofluorescence and microbiology. Tzanck smear is a rapid bedside test but cannot by itself establish every immunobullous diagnosis. If diagnostic accuracy is claimed, the reference standard must be explicit and as independent as possible.
Biopsy-site selection: Routine histopathology and direct immunofluorescence may require different tissue sites. The protocol should specify whether the specimen is taken from a fresh intact blister, lesional skin or perilesional skin, and should avoid relying on eroded, infected or extensively necrotic tissue when this would reduce diagnostic yield.
Severity and outcome measurement: Disease-specific instruments such as the Pemphigus Disease Area Index should not be substituted with generic body surface area measures without justification. Mucosal burden, secondary infection, re-epithelialisation, scarring and treatment toxicity are separate outcomes and should be defined before enrolment.
Blistering skin conditions synopsis versus blistering skin conditions protocol
The synopsis gives the academic committee the research question, rationale, objectives, study design, broad methods, sample size, statistical approach and ethics in concise form. It should establish that the project is feasible within the available patient load and diagnostic services.
The full protocol must specify the operational details that determine diagnostic validity in blistering disease: which lesion is examined, where biopsy is taken, how direct immunofluorescence tissue is transported, how mucosal involvement is recorded, what qualifies as secondary infection and how treatment response is measured.
For diagnostic studies, the protocol should also explain blinding, verification of clinically negative or atypical cases and handling of discordant histopathology and immunofluorescence findings. For drug-induced and infectious blistering disorders, it should define the clinical reference pathway separately rather than applying an autoimmune template.
Sample size and statistical analysis
Sample size should be calculated from the primary objective. Profile studies need an expected proportion and precision; comparative studies need an anticipated between-group difference; case-control studies need an expected exposure difference; and prospective response studies need an expected change in the predefined severity or healing outcome.
Correlation between Tzanck smear findings, dermoscopy, histopathology and severity scores does not establish diagnostic accuracy. Sensitivity and specificity require a clearly defined reference standard applied to an appropriate spectrum of patients. If confirmatory biopsy or immunofluorescence is performed only in selected cases, partial verification bias should be acknowledged.
Repeated severity measurements, mucosal scores or healing assessments require paired or longitudinal analysis. Multivariable models should remain realistic for the available sample, particularly in uncommon diseases, and should account for clinically important factors such as age, disease extent, mucosal involvement, infection and prior systemic treatment when relevant.
Frequently Asked Questions – Blistering Skin Conditions Thesis Topics (2026–27)
1. How should I choose a feasible blistering skin conditions thesis topic for 2026–2027 MD Dermatology admissions?
Choose a clearly defined vesiculobullous disorder or a tightly related comparison group that matches the department's case-load and routine diagnostic facilities. Feasible projects commonly use clinical examination, disease-specific severity assessment, Tzanck smear, dermoscopy, routine histopathology, direct immunofluorescence when clinically indicated, microbiology for infected erosions and standard follow-up. Avoid combining autoimmune, infectious and drug-induced blistering disorders unless the research question is explicitly comparative.
2. Which study designs are suitable for blistering skin conditions research?
Cross-sectional observational and analytical studies suit clinical profile, mucosal involvement, severity, quality of life, dermoscopic findings and laboratory correlations. Comparative cross-sectional designs are useful for pemphigus vulgaris versus pemphigus foliaceus, pemphigus versus bullous pemphigoid, or other clinically overlapping conditions. Case-control studies can examine factors associated with extensive disease, mucosal involvement, scarring or secondary infection. Prospective observational studies suit early response, adverse effects and healing during routine treatment.
3. What should I settle with my guide before finalising a blistering skin conditions protocol?
Fix the exact diagnosis, lesion type to be sampled, biopsy site, direct immunofluorescence pathway, primary severity outcome and treatment exposure before recruitment. The protocol should state whether the reference diagnosis is based on clinical findings, histopathology, direct immunofluorescence, microbiology or a predefined composite. It should also define how eroded, infected, treated and clinically atypical lesions will be handled.
4. How should rare blistering disorders be studied in a thesis?
Rare disorders such as epidermolysis bullosa acquisita, mucous membrane pemphigoid and linear immunoglobulin A bullous dermatosis are often better suited to retrospective cohorts, descriptive case series or multicondition comparative studies than to small underpowered prospective trials. Extending the record-review period can improve sample size if diagnostic documentation is reliable. The protocol should state clearly when analysis is descriptive and avoid unstable multivariable models in very small subgroups.
5. What is the difference between a blistering skin conditions synopsis and protocol?
The synopsis is the concise academic submission containing the research question, rationale, objectives, design, sample size, broad methods, analysis and ethics. The full protocol is the operational document and should specify lesion selection, Tzanck smear technique, histopathology site, direct immunofluorescence site and transport, mucosal assessment, infection definitions, treatment exposure, follow-up windows and statistical methods in enough detail for another investigator to reproduce the study.
6. What ethical issues should a blistering skin conditions thesis address?
For children, guardian consent and child assent from about seven years should be addressed according to institutional policy. Record-based work may seek a consent waiver where permitted. No extra biopsy, direct immunofluorescence, culture, blood sampling or treatment should be added solely for research unless specifically justified and approved, and any research-only venepuncture should state a blood volume limit. Separate consent should cover identifiable clinical photographs and video. The protocol should also define escalation for severe mucosal disease, ocular involvement, extensive epidermal detachment, secondary infection, treatment toxicity, suspected Stevens-Johnson syndrome or toxic epidermal necrolysis, and rapidly progressive blistering.
7. What is the sharpest methodological problem in blistering skin conditions research?
The sharpest problem is incorrect sampling and reference-standard bias. Routine histopathology and direct immunofluorescence frequently require different biopsy sites, and sampling an eroded, infected or fully blistered area can reduce diagnostic yield. A study should therefore state exactly where each specimen is taken, how it is transported and which result establishes the diagnosis. If only selected clinically typical cases undergo immunofluorescence, sensitivity and specificity estimates may be biased.
8. Can a blistering skin conditions topic be adapted for PhD, Saudi Board, Arab Board or Gulf research requirements?
Yes. An MD synopsis usually addresses a focused clinical question that can be completed during residency, whereas a PhD proposal requires a broader conceptual framework, deeper methodological justification and usually a programme of work. Board pathways may also require a separate research project, including SCFHS and Saudi Board requirements, the Arab Board of Health Specializations, and research components linked to DHP, DHA, DOH and MOHAP training programmes. The core blistering-disease question can often be retained, but diagnostic pathways, sample size and governance should be adapted to the relevant institution or board.
9. When should I register my blistering skin conditions thesis?
Registration and institutional approvals should be completed before prospective recruitment or study-specific data collection begins. The final protocol, diagnostic criteria, lesion-selection method, biopsy and direct immunofluorescence pathway, treatment definitions and statistical plan should be settled first. Retrospective studies should clarify ethics approval and access to pathology, immunofluorescence, microbiology and clinical records before extraction.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
